Priscilla Kalliope Brastianos, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Neoplasms | 26 | 2018 | 8824 | 2.180 |
Why?
|
Meningeal Neoplasms | 10 | 2018 | 1239 | 1.450 |
Why?
|
Meningioma | 9 | 2018 | 1205 | 1.330 |
Why?
|
Craniopharyngioma | 3 | 2015 | 281 | 1.260 |
Why?
|
Molecular Targeted Therapy | 8 | 2018 | 2738 | 1.090 |
Why?
|
Meningeal Carcinomatosis | 2 | 2017 | 65 | 0.980 |
Why?
|
Pituitary Neoplasms | 4 | 2016 | 1334 | 0.920 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2015 | 2039 | 0.760 |
Why?
|
Central Nervous System Neoplasms | 3 | 2018 | 897 | 0.660 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2010 | 773 | 0.650 |
Why?
|
Seminoma | 1 | 2018 | 140 | 0.590 |
Why?
|
Dystrophin | 1 | 2018 | 285 | 0.590 |
Why?
|
Meningitis | 1 | 2018 | 219 | 0.570 |
Why?
|
Angiogenesis Inhibitors | 3 | 2011 | 2038 | 0.550 |
Why?
|
Gene Fusion | 1 | 2018 | 378 | 0.510 |
Why?
|
Antineoplastic Agents | 7 | 2017 | 13663 | 0.480 |
Why?
|
Radiotherapy | 2 | 2017 | 1531 | 0.440 |
Why?
|
Poetry as Topic | 1 | 2012 | 17 | 0.430 |
Why?
|
Genomics | 3 | 2016 | 5693 | 0.390 |
Why?
|
Melanoma | 4 | 2016 | 5456 | 0.370 |
Why?
|
Gene Deletion | 1 | 2018 | 2765 | 0.370 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 787 | 0.370 |
Why?
|
Point Mutation | 1 | 2015 | 1627 | 0.360 |
Why?
|
Glioma | 6 | 2018 | 3389 | 0.360 |
Why?
|
Carbazoles | 3 | 2016 | 228 | 0.360 |
Why?
|
Neovascularization, Pathologic | 2 | 2010 | 2640 | 0.350 |
Why?
|
Neurosurgical Procedures | 2 | 2017 | 1994 | 0.350 |
Why?
|
Sacrum | 2 | 2009 | 289 | 0.340 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2009 | 73 | 0.320 |
Why?
|
Skin Neoplasms | 3 | 2016 | 5655 | 0.310 |
Why?
|
Primary Myelofibrosis | 1 | 2009 | 213 | 0.300 |
Why?
|
Isocitrate Dehydrogenase | 3 | 2018 | 874 | 0.300 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1218 | 0.260 |
Why?
|
Osteochondroma | 1 | 2005 | 47 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2016 | 2510 | 0.260 |
Why?
|
Mutation | 12 | 2018 | 29819 | 0.250 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2012 | 1378 | 0.250 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2902 | 0.250 |
Why?
|
Injections, Spinal | 2 | 2017 | 304 | 0.240 |
Why?
|
Immunotherapy | 2 | 2017 | 4394 | 0.240 |
Why?
|
Valine | 2 | 2015 | 413 | 0.240 |
Why?
|
Piperidines | 3 | 2016 | 1605 | 0.230 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2006 | 257 | 0.220 |
Why?
|
Telomerase | 2 | 2018 | 731 | 0.210 |
Why?
|
Humans | 51 | 2018 | 740505 | 0.200 |
Why?
|
Lung Neoplasms | 6 | 2016 | 13046 | 0.200 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2016 | 9155 | 0.200 |
Why?
|
Spinal Neoplasms | 2 | 2005 | 758 | 0.190 |
Why?
|
Craniotomy | 2 | 2015 | 729 | 0.190 |
Why?
|
Thoracic Vertebrae | 1 | 2005 | 608 | 0.190 |
Why?
|
Glutamic Acid | 2 | 2015 | 1173 | 0.180 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2006 | 808 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 4 | 2018 | 5524 | 0.180 |
Why?
|
Bone Marrow | 1 | 2009 | 2946 | 0.170 |
Why?
|
Sex Chromatin | 1 | 2018 | 20 | 0.170 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9423 | 0.170 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4206 | 0.160 |
Why?
|
Cyanides | 1 | 2018 | 84 | 0.160 |
Why?
|
Spinal Cord Neoplasms | 2 | 2014 | 282 | 0.160 |
Why?
|
Guanidines | 1 | 2018 | 191 | 0.150 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2015 | 1672 | 0.150 |
Why?
|
Prognosis | 7 | 2018 | 28979 | 0.150 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 719 | 0.140 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2015 | 25 | 0.140 |
Why?
|
Tumor Microenvironment | 3 | 2017 | 3517 | 0.130 |
Why?
|
Cranial Irradiation | 1 | 2018 | 403 | 0.130 |
Why?
|
Neurofibromin 2 | 2 | 2014 | 270 | 0.130 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6749 | 0.130 |
Why?
|
Rhabdoid Tumor | 1 | 2017 | 213 | 0.130 |
Why?
|
Neoplasms | 2 | 2015 | 21558 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11424 | 0.130 |
Why?
|
Combined Modality Therapy | 3 | 2017 | 8610 | 0.130 |
Why?
|
Cerebrospinal Fluid | 1 | 2017 | 536 | 0.120 |
Why?
|
Chromosomes, Human | 1 | 2016 | 456 | 0.120 |
Why?
|
Hemangioblastoma | 1 | 2014 | 71 | 0.120 |
Why?
|
Oximes | 1 | 2015 | 309 | 0.120 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2017 | 454 | 0.120 |
Why?
|
Tumor Suppressor Proteins | 2 | 2017 | 2856 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2015 | 3651 | 0.120 |
Why?
|
Cell Line, Tumor | 6 | 2018 | 16684 | 0.120 |
Why?
|
Breast Neoplasms | 3 | 2016 | 20711 | 0.120 |
Why?
|
Cathepsins | 1 | 2014 | 238 | 0.110 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 290 | 0.110 |
Why?
|
Pyrimidinones | 1 | 2015 | 372 | 0.110 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2014 | 404 | 0.110 |
Why?
|
Blood-Brain Barrier | 2 | 2016 | 1016 | 0.110 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2015 | 619 | 0.110 |
Why?
|
Turner Syndrome | 1 | 2014 | 130 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2016 | 5183 | 0.110 |
Why?
|
Genotype | 2 | 2018 | 12971 | 0.110 |
Why?
|
Gadolinium | 1 | 2017 | 951 | 0.110 |
Why?
|
Symbolism | 1 | 2012 | 34 | 0.110 |
Why?
|
Simplexvirus | 1 | 2016 | 804 | 0.100 |
Why?
|
Disease Progression | 3 | 2018 | 13277 | 0.100 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 727 | 0.100 |
Why?
|
Base Sequence | 2 | 2014 | 12816 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 8 | 2018 | 35347 | 0.100 |
Why?
|
Cisterna Magna | 1 | 2011 | 41 | 0.100 |
Why?
|
Injections, Intraventricular | 1 | 2011 | 232 | 0.100 |
Why?
|
Survival | 1 | 2011 | 162 | 0.100 |
Why?
|
Dancing | 1 | 2012 | 101 | 0.100 |
Why?
|
Pyridones | 1 | 2015 | 707 | 0.100 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 976 | 0.090 |
Why?
|
Survival Analysis | 3 | 2018 | 10255 | 0.090 |
Why?
|
Oncolytic Virotherapy | 1 | 2016 | 489 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 610 | 0.090 |
Why?
|
DNA Modification Methylases | 1 | 2011 | 210 | 0.090 |
Why?
|
Cerebellar Neoplasms | 1 | 2014 | 609 | 0.090 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 1029 | 0.090 |
Why?
|
Imidazoles | 1 | 2015 | 1215 | 0.090 |
Why?
|
DNA Repair Enzymes | 1 | 2011 | 352 | 0.090 |
Why?
|
Comparative Genomic Hybridization | 3 | 2016 | 505 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 7904 | 0.080 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 4847 | 0.080 |
Why?
|
Male | 19 | 2018 | 349593 | 0.080 |
Why?
|
beta Catenin | 1 | 2014 | 1059 | 0.080 |
Why?
|
Cluster Analysis | 1 | 2015 | 2721 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1525 | 0.080 |
Why?
|
Injections | 1 | 2011 | 838 | 0.080 |
Why?
|
Sequence Analysis, DNA | 3 | 2014 | 4815 | 0.080 |
Why?
|
Chromosome Aberrations | 1 | 2014 | 1825 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 3 | 2015 | 6530 | 0.080 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4940 | 0.080 |
Why?
|
Neurotoxicity Syndromes | 1 | 2011 | 290 | 0.080 |
Why?
|
Biopsy | 2 | 2009 | 6763 | 0.070 |
Why?
|
Rabbits | 2 | 2011 | 4897 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2452 | 0.070 |
Why?
|
Mice, SCID | 3 | 2018 | 2716 | 0.070 |
Why?
|
Signal Transduction | 3 | 2015 | 23397 | 0.070 |
Why?
|
Adult | 13 | 2018 | 213729 | 0.070 |
Why?
|
Genetic Vectors | 1 | 2016 | 3419 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2936 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3708 | 0.070 |
Why?
|
RNA, Messenger | 2 | 2018 | 13013 | 0.070 |
Why?
|
Female | 18 | 2018 | 379368 | 0.070 |
Why?
|
Bayes Theorem | 1 | 2014 | 2303 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2015 | 1569 | 0.070 |
Why?
|
Orthopedic Fixation Devices | 1 | 2005 | 75 | 0.070 |
Why?
|
Blood Cell Count | 1 | 2006 | 404 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2014 | 2555 | 0.060 |
Why?
|
Contrast Media | 1 | 2017 | 5293 | 0.060 |
Why?
|
Laminectomy | 1 | 2005 | 233 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2018 | 3569 | 0.060 |
Why?
|
Radiosurgery | 1 | 2013 | 1307 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2015 | 3466 | 0.060 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11446 | 0.060 |
Why?
|
Animals | 8 | 2018 | 168756 | 0.060 |
Why?
|
Trans-Activators | 1 | 2013 | 2925 | 0.060 |
Why?
|
Review Literature as Topic | 1 | 2005 | 329 | 0.060 |
Why?
|
Patient Selection | 1 | 2015 | 4223 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2018 | 3114 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2009 | 12992 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15070 | 0.050 |
Why?
|
Middle Aged | 11 | 2018 | 213217 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2015 | 2987 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 18139 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5162 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4574 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2011 | 3505 | 0.050 |
Why?
|
Anesthesia | 1 | 2011 | 1547 | 0.050 |
Why?
|
Genetic Variation | 1 | 2015 | 6549 | 0.050 |
Why?
|
Abdominal Pain | 1 | 2006 | 1055 | 0.040 |
Why?
|
Aged | 7 | 2018 | 162955 | 0.040 |
Why?
|
Acute Disease | 1 | 2009 | 7137 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2015 | 62758 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2018 | 57769 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3506 | 0.040 |
Why?
|
Cohort Studies | 2 | 2018 | 40437 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2011 | 3624 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9279 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16333 | 0.040 |
Why?
|
Mice, Nude | 2 | 2014 | 3697 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2016 | 1957 | 0.040 |
Why?
|
DNA Methylation | 1 | 2011 | 4286 | 0.040 |
Why?
|
Adolescent | 3 | 2018 | 85503 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12188 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15519 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2009 | 20060 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 1 | 2006 | 1819 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 278 | 0.030 |
Why?
|
Radiography | 1 | 2006 | 7000 | 0.030 |
Why?
|
Frozen Sections | 1 | 2015 | 154 | 0.030 |
Why?
|
Cystatins | 1 | 2014 | 55 | 0.030 |
Why?
|
Young Adult | 2 | 2018 | 56363 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2015 | 522 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2015 | 247 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 323 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 942 | 0.030 |
Why?
|
Carcinoma | 1 | 2005 | 2383 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17420 | 0.030 |
Why?
|
Serpins | 1 | 2014 | 248 | 0.030 |
Why?
|
SEER Program | 1 | 2018 | 1506 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1806 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 893 | 0.030 |
Why?
|
3T3 Cells | 1 | 2013 | 1103 | 0.020 |
Why?
|
Gene Dosage | 1 | 2016 | 1258 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2014 | 792 | 0.020 |
Why?
|
Child, Preschool | 2 | 2013 | 40847 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2009 | 38972 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1869 | 0.020 |
Why?
|
Multigene Family | 1 | 2013 | 1107 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 2006 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1804 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 2000 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1383 | 0.020 |
Why?
|
Survival Rate | 2 | 2015 | 12782 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1250 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2438 | 0.020 |
Why?
|
Mice | 4 | 2018 | 81104 | 0.020 |
Why?
|
Cell Lineage | 1 | 2017 | 2491 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1546 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6314 | 0.020 |
Why?
|
Virus Replication | 1 | 2016 | 2531 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 2672 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4753 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5194 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4223 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 2222 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2142 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2005 | 18036 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2011 | 1339 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3854 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6188 | 0.020 |
Why?
|
Brain | 1 | 2012 | 26350 | 0.020 |
Why?
|
Insurance, Health | 1 | 2018 | 2497 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2018 | 76733 | 0.020 |
Why?
|
Child | 2 | 2013 | 77137 | 0.020 |
Why?
|
Medical Illustration | 1 | 2005 | 134 | 0.020 |
Why?
|
Embolism, Fat | 1 | 2003 | 47 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7733 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5869 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6889 | 0.010 |
Why?
|
Genome, Human | 1 | 2016 | 4431 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13413 | 0.010 |
Why?
|
Internal Fixators | 1 | 2003 | 189 | 0.010 |
Why?
|
Rectal Diseases | 1 | 2003 | 142 | 0.010 |
Why?
|
Macrophages | 1 | 2017 | 5630 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5239 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2526 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6951 | 0.010 |
Why?
|
Intestinal Perforation | 1 | 2003 | 252 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4425 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2003 | 15210 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2005 | 2085 | 0.010 |
Why?
|
Chondrosarcoma | 1 | 2003 | 310 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18362 | 0.010 |
Why?
|
Bone Plates | 1 | 2003 | 467 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8430 | 0.010 |
Why?
|
Chordoma | 1 | 2003 | 359 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10477 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9743 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 40111 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14567 | 0.010 |
Why?
|
Risk Factors | 2 | 2018 | 72030 | 0.010 |
Why?
|
Bone Transplantation | 1 | 2003 | 894 | 0.010 |
Why?
|
Osteosarcoma | 1 | 2003 | 886 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2003 | 4773 | 0.010 |
Why?
|
Spinal Fusion | 1 | 2003 | 1236 | 0.010 |
Why?
|
Surgical Wound Infection | 1 | 2003 | 1530 | 0.010 |
Why?
|
Sepsis | 1 | 2003 | 2578 | 0.010 |
Why?
|